Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Pain Responder Analysis: Use of Area Under the Curve to Enhance Interpretation of Clinical Trial Results
Pain Practice, 06/23/09
Cappelleri JC et al. - Interpretation of results on patient-reported pain outcomes from clinical trials should be meaningful to patients and healthcare providers. This study applied an area-under-the-curve (AUC) analysis to responder profiles in a clinical trial of pregabalin for the treatment of fibromyalgia (FM)...Pain improvement was significantly better with pregabalin, with pregabalin responders improving by 8.4% (300 mg/day), 10.7% (450 mg/day), and 12.5% (600 mg/day) more than placebo responders. This novel approach demonstrates that responder profiles can provide an enhanced interpretation of pain outcomes for patient care and symptom management.
Related Articles
Advances in fibromyalgia treatment: understanding endogenous pain modulation
International Journal of Clinical Rheumatology, 11/09/09
Relevance Score: 67%
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations
Pain, 10/20/09
Relevance Score: 65%
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
Journal of Rheumatology, 10/15/09
Relevance Score: 64%
Cluster Headache As the Result of Secondhand Cigarette Smoke Exposure During Childhood
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 63%
Pain among Veterans of Operations Enduring Freedom and Iraqi Freedom: Do Women and Men Differ?
Pain Medicine, 10/13/09
Relevance Score: 49%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
BMC Infectious Diseases, 12/03/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/03/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09
The Roles of Pharmacists in Pain Management
Journal Of Pain & Palliative Care Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


